

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.28731329 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.19642774 |
| 3 | synaptic vesicle maturation (GO:0016188) | 6.09785157 |
| 4 | locomotory exploration behavior (GO:0035641) | 6.09019654 |
| 5 | vocalization behavior (GO:0071625) | 5.60159949 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.55697166 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.47746627 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.34034886 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.20918303 |
| 10 | regulation of synapse structural plasticity (GO:0051823) | 5.16024352 |
| 11 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.12867565 |
| 12 | regulation of neuronal synaptic plasticity (GO:0048168) | 5.05085507 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.01527742 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.96687267 |
| 15 | protein localization to synapse (GO:0035418) | 4.95310290 |
| 16 | glutamate secretion (GO:0014047) | 4.87587732 |
| 17 | exploration behavior (GO:0035640) | 4.82264044 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.78265280 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.50283414 |
| 20 | dendritic spine morphogenesis (GO:0060997) | 4.39135231 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.39079672 |
| 22 | glutamate receptor signaling pathway (GO:0007215) | 4.38853503 |
| 23 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.37902038 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.37136215 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.33337358 |
| 26 | long-term memory (GO:0007616) | 4.31978815 |
| 27 | layer formation in cerebral cortex (GO:0021819) | 4.31305767 |
| 28 | neurotransmitter secretion (GO:0007269) | 4.26146282 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 4.21741196 |
| 30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.18956160 |
| 31 | neuronal action potential propagation (GO:0019227) | 4.16882780 |
| 32 | neuron cell-cell adhesion (GO:0007158) | 4.12293523 |
| 33 | positive regulation of membrane potential (GO:0045838) | 4.12164815 |
| 34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.10755021 |
| 35 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.09788322 |
| 36 | presynaptic membrane organization (GO:0097090) | 4.02764332 |
| 37 | regulation of synaptic plasticity (GO:0048167) | 4.00309333 |
| 38 | L-amino acid import (GO:0043092) | 3.96353136 |
| 39 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.96114660 |
| 40 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.93409702 |
| 41 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.92359226 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 3.90698734 |
| 43 | prepulse inhibition (GO:0060134) | 3.89549253 |
| 44 | presynaptic membrane assembly (GO:0097105) | 3.89309484 |
| 45 | cell migration in hindbrain (GO:0021535) | 3.89008069 |
| 46 | positive regulation of synapse maturation (GO:0090129) | 3.88566076 |
| 47 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.87008095 |
| 48 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.83878944 |
| 49 | neuromuscular process controlling balance (GO:0050885) | 3.83735255 |
| 50 | establishment of mitochondrion localization (GO:0051654) | 3.81802225 |
| 51 | cerebellar granule cell differentiation (GO:0021707) | 3.79512698 |
| 52 | auditory behavior (GO:0031223) | 3.75908931 |
| 53 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.73545847 |
| 54 | long-term synaptic potentiation (GO:0060291) | 3.70858382 |
| 55 | positive regulation of neurotransmitter transport (GO:0051590) | 3.69241328 |
| 56 | gamma-aminobutyric acid transport (GO:0015812) | 3.68504963 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.66170983 |
| 58 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.64901292 |
| 59 | behavioral defense response (GO:0002209) | 3.64480633 |
| 60 | behavioral fear response (GO:0001662) | 3.64480633 |
| 61 | transmission of nerve impulse (GO:0019226) | 3.63170448 |
| 62 | regulation of female receptivity (GO:0045924) | 3.62199696 |
| 63 | cellular potassium ion homeostasis (GO:0030007) | 3.61629247 |
| 64 | proline transport (GO:0015824) | 3.58962335 |
| 65 | activation of protein kinase A activity (GO:0034199) | 3.58850424 |
| 66 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.58624378 |
| 67 | synaptic transmission, dopaminergic (GO:0001963) | 3.56729638 |
| 68 | regulation of dendritic spine development (GO:0060998) | 3.56396911 |
| 69 | amino acid import (GO:0043090) | 3.55102039 |
| 70 | neuromuscular synaptic transmission (GO:0007274) | 3.52255089 |
| 71 | response to auditory stimulus (GO:0010996) | 3.49725912 |
| 72 | dendritic spine organization (GO:0097061) | 3.49561375 |
| 73 | positive regulation of dendritic spine development (GO:0060999) | 3.48413621 |
| 74 | neuron recognition (GO:0008038) | 3.47437489 |
| 75 | nucleobase catabolic process (GO:0046113) | 3.46705346 |
| 76 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.46629036 |
| 77 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.44890069 |
| 78 | neurotransmitter transport (GO:0006836) | 3.37246030 |
| 79 | regulation of glutamate secretion (GO:0014048) | 3.37146694 |
| 80 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.37074428 |
| 81 | neuronal ion channel clustering (GO:0045161) | 3.36971723 |
| 82 | mitochondrion transport along microtubule (GO:0047497) | 3.36919681 |
| 83 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.36919681 |
| 84 | response to histamine (GO:0034776) | 3.35737103 |
| 85 | dopamine receptor signaling pathway (GO:0007212) | 3.35724495 |
| 86 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.33890749 |
| 87 | learning (GO:0007612) | 3.32380730 |
| 88 | striatum development (GO:0021756) | 3.31185159 |
| 89 | fear response (GO:0042596) | 3.30397551 |
| 90 | regulation of neurotransmitter secretion (GO:0046928) | 3.30294680 |
| 91 | sodium ion export (GO:0071436) | 3.30094937 |
| 92 | regulation of vesicle fusion (GO:0031338) | 3.29747678 |
| 93 | synaptic vesicle endocytosis (GO:0048488) | 3.29474574 |
| 94 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.28194026 |
| 95 | response to amphetamine (GO:0001975) | 3.27093698 |
| 96 | behavioral response to cocaine (GO:0048148) | 3.26594758 |
| 97 | neurofilament cytoskeleton organization (GO:0060052) | 3.24214886 |
| 98 | regulation of synapse maturation (GO:0090128) | 3.23942597 |
| 99 | membrane depolarization (GO:0051899) | 3.23242365 |
| 100 | membrane depolarization during action potential (GO:0086010) | 3.23120832 |
| 101 | regulation of neurotransmitter levels (GO:0001505) | 3.21815494 |
| 102 | female mating behavior (GO:0060180) | 3.21764656 |
| 103 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.21369012 |
| 104 | vesicle transport along microtubule (GO:0047496) | 3.20747797 |
| 105 | positive regulation of synaptic transmission (GO:0050806) | 3.19411962 |
| 106 | cell communication by electrical coupling (GO:0010644) | 3.17988908 |
| 107 | innervation (GO:0060384) | 3.17978393 |
| 108 | mechanosensory behavior (GO:0007638) | 3.16491720 |
| 109 | axonal fasciculation (GO:0007413) | 3.15874321 |
| 110 | central nervous system myelination (GO:0022010) | 3.14724087 |
| 111 | axon ensheathment in central nervous system (GO:0032291) | 3.14724087 |
| 112 | regulation of neurotransmitter transport (GO:0051588) | 3.14545904 |
| 113 | membrane hyperpolarization (GO:0060081) | 3.09825078 |
| 114 | adult walking behavior (GO:0007628) | 3.09604613 |
| 115 | regulation of synaptic transmission (GO:0050804) | 3.09136935 |
| 116 | synaptic transmission (GO:0007268) | 3.07732310 |
| 117 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.07666642 |
| 118 | postsynaptic membrane organization (GO:0001941) | 3.06984030 |
| 119 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.06401957 |
| 120 | neuromuscular process (GO:0050905) | 3.05439814 |
| 121 | visual learning (GO:0008542) | 3.04807314 |
| 122 | negative regulation of amino acid transport (GO:0051956) | 3.04124267 |
| 123 | dendrite morphogenesis (GO:0048813) | 3.02274891 |
| 124 | long term synaptic depression (GO:0060292) | 3.02113588 |
| 125 | neuromuscular process controlling posture (GO:0050884) | 3.00952104 |
| 126 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.00337011 |
| 127 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.99367613 |
| 128 | acidic amino acid transport (GO:0015800) | 2.99194475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.00626419 |
| 2 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.36099165 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.33035781 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.23499176 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.17962826 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.13715680 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.88790194 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.81659143 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.81659143 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.77457795 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72073344 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.71060519 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.63506704 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.62404701 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53749527 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52575726 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.51478126 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.49704606 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.39007776 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.37997430 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.32594967 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.31732175 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.26490982 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.20215243 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.18718365 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.07937348 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.04158957 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89739908 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.89603124 |
| 30 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.62956840 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59256198 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57742379 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51337294 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50321208 |
| 35 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.50200237 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47228252 |
| 37 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.41732257 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.41723641 |
| 39 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.39070057 |
| 40 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.38807920 |
| 41 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38245276 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35368456 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31845730 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29330789 |
| 45 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.27912569 |
| 46 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26811209 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25444040 |
| 48 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24647731 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24151517 |
| 50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23391085 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22970235 |
| 52 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22522763 |
| 53 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22463169 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22383736 |
| 55 | AR_19668381_ChIP-Seq_PC3_Human | 1.21222195 |
| 56 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20666600 |
| 57 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20218698 |
| 58 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.20218698 |
| 59 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18998236 |
| 60 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.17820575 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16894075 |
| 62 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16003972 |
| 63 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.15922275 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15320089 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15149109 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14915638 |
| 67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14782489 |
| 68 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.14145720 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14085102 |
| 70 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.13873756 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12974611 |
| 72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10497670 |
| 73 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10481156 |
| 74 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05829394 |
| 75 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05444228 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05004271 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04483898 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03372143 |
| 79 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.03195553 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02126622 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01933012 |
| 82 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00883775 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00487388 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00408658 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99872848 |
| 86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99344711 |
| 87 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98915714 |
| 88 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98381927 |
| 89 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97936211 |
| 90 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96852518 |
| 91 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.96380167 |
| 92 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94154054 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94058929 |
| 94 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.93839558 |
| 95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93687896 |
| 96 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.93433948 |
| 97 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.92681231 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92550295 |
| 99 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91010267 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90886622 |
| 101 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90728532 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90220747 |
| 103 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89588854 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88046554 |
| 105 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87532674 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86976240 |
| 107 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.84781019 |
| 108 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84508128 |
| 109 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.83967748 |
| 110 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.83214614 |
| 111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82698695 |
| 112 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82697341 |
| 113 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82211102 |
| 114 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82004062 |
| 115 | JUN_21703547_ChIP-Seq_K562_Human | 0.81318415 |
| 116 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81113964 |
| 117 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.80919922 |
| 118 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.79301785 |
| 119 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76483106 |
| 120 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.75496847 |
| 121 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.74398733 |
| 122 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.74190644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.51169763 |
| 2 | MP0003880_abnormal_central_pattern | 5.02704418 |
| 3 | MP0002822_catalepsy | 4.84553171 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.44652530 |
| 5 | MP0004270_analgesia | 3.80010237 |
| 6 | MP0009745_abnormal_behavioral_response | 3.70949026 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.69422656 |
| 8 | MP0002064_seizures | 3.21520708 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.92705087 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.85008420 |
| 11 | MP0009046_muscle_twitch | 2.76221373 |
| 12 | MP0001486_abnormal_startle_reflex | 2.64539408 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.62690732 |
| 14 | MP0002272_abnormal_nervous_system | 2.54944581 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.42391390 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.32923965 |
| 17 | MP0002736_abnormal_nociception_after | 2.17078984 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.05315579 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.02188581 |
| 20 | MP0002909_abnormal_adrenal_gland | 1.97186320 |
| 21 | MP0002735_abnormal_chemical_nociception | 1.97078177 |
| 22 | MP0003329_amyloid_beta_deposits | 1.93203392 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.87523727 |
| 24 | MP0001970_abnormal_pain_threshold | 1.86164002 |
| 25 | MP0004811_abnormal_neuron_physiology | 1.82668182 |
| 26 | MP0003123_paternal_imprinting | 1.78319193 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.76130891 |
| 28 | MP0004924_abnormal_behavior | 1.76130891 |
| 29 | MP0008569_lethality_at_weaning | 1.75082681 |
| 30 | MP0001529_abnormal_vocalization | 1.74705208 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.72436652 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.70248478 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.68820595 |
| 34 | MP0004858_abnormal_nervous_system | 1.64145796 |
| 35 | MP0000778_abnormal_nervous_system | 1.63585307 |
| 36 | MP0002184_abnormal_innervation | 1.59193973 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.59046420 |
| 38 | MP0003879_abnormal_hair_cell | 1.58922596 |
| 39 | MP0004885_abnormal_endolymph | 1.48435534 |
| 40 | MP0000955_abnormal_spinal_cord | 1.46368158 |
| 41 | MP0001984_abnormal_olfaction | 1.43788794 |
| 42 | MP0003121_genomic_imprinting | 1.41090143 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.38949059 |
| 44 | MP0003633_abnormal_nervous_system | 1.35950539 |
| 45 | MP0003787_abnormal_imprinting | 1.35300700 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.33754565 |
| 47 | MP0003075_altered_response_to | 1.31165727 |
| 48 | MP0001905_abnormal_dopamine_level | 1.24357974 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.23395857 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.14857785 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.12926144 |
| 52 | MP0001188_hyperpigmentation | 1.12301996 |
| 53 | MP0003631_nervous_system_phenotype | 1.12077760 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.10105389 |
| 55 | MP0008874_decreased_physiological_sensi | 1.07664561 |
| 56 | MP0008872_abnormal_physiological_respon | 1.07073152 |
| 57 | MP0002152_abnormal_brain_morphology | 1.05948142 |
| 58 | MP0001177_atelectasis | 1.03813254 |
| 59 | MP0005409_darkened_coat_color | 1.02187867 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.01341258 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 0.99609643 |
| 62 | MP0006292_abnormal_olfactory_placode | 0.97307423 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 0.96827745 |
| 64 | MP0003283_abnormal_digestive_organ | 0.95893460 |
| 65 | MP0008961_abnormal_basal_metabolism | 0.94528422 |
| 66 | MP0004142_abnormal_muscle_tone | 0.94281740 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.92503692 |
| 68 | MP0000604_amyloidosis | 0.90656528 |
| 69 | MP0000751_myopathy | 0.89077003 |
| 70 | MP0005535_abnormal_body_temperature | 0.88891304 |
| 71 | MP0004085_abnormal_heartbeat | 0.87513362 |
| 72 | MP0002229_neurodegeneration | 0.85172451 |
| 73 | MP0003690_abnormal_glial_cell | 0.83804333 |
| 74 | MP0000013_abnormal_adipose_tissue | 0.83335804 |
| 75 | MP0002090_abnormal_vision | 0.82666621 |
| 76 | MP0001346_abnormal_lacrimal_gland | 0.82324943 |
| 77 | MP0000569_abnormal_digit_pigmentation | 0.81649358 |
| 78 | MP0005499_abnormal_olfactory_system | 0.77746631 |
| 79 | MP0005394_taste/olfaction_phenotype | 0.77746631 |
| 80 | MP0005551_abnormal_eye_electrophysiolog | 0.77450400 |
| 81 | MP0003890_abnormal_embryonic-extraembry | 0.76517349 |
| 82 | MP0004133_heterotaxia | 0.76350804 |
| 83 | MP0003634_abnormal_glial_cell | 0.75213776 |
| 84 | MP0003122_maternal_imprinting | 0.75121534 |
| 85 | MP0003119_abnormal_digestive_system | 0.73278746 |
| 86 | MP0000920_abnormal_myelination | 0.72365267 |
| 87 | MP0003938_abnormal_ear_development | 0.72174382 |
| 88 | MP0004510_myositis | 0.72092350 |
| 89 | MP0001299_abnormal_eye_distance/ | 0.71941183 |
| 90 | MP0003632_abnormal_nervous_system | 0.71103307 |
| 91 | MP0002751_abnormal_autonomic_nervous | 0.69912564 |
| 92 | MP0002102_abnormal_ear_morphology | 0.66231984 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.66155623 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.65337576 |
| 95 | MP0010386_abnormal_urinary_bladder | 0.64550653 |
| 96 | MP0001963_abnormal_hearing_physiology | 0.64160340 |
| 97 | MP0000026_abnormal_inner_ear | 0.64139243 |
| 98 | MP0010770_preweaning_lethality | 0.63627046 |
| 99 | MP0002082_postnatal_lethality | 0.63627046 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.62522008 |
| 101 | MP0010768_mortality/aging | 0.61779098 |
| 102 | MP0001664_abnormal_digestion | 0.61669837 |
| 103 | MP0004742_abnormal_vestibular_system | 0.61171233 |
| 104 | MP0002081_perinatal_lethality | 0.60502612 |
| 105 | MP0002752_abnormal_somatic_nervous | 0.59912377 |
| 106 | MP0001348_abnormal_lacrimal_gland | 0.59438448 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.59014790 |
| 108 | MP0004145_abnormal_muscle_electrophysio | 0.58873678 |
| 109 | MP0004147_increased_porphyrin_level | 0.57606290 |
| 110 | MP0004484_altered_response_of | 0.57193517 |
| 111 | MP0008789_abnormal_olfactory_epithelium | 0.56866071 |
| 112 | MP0005187_abnormal_penis_morphology | 0.56061027 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.56028843 |
| 114 | MP0004233_abnormal_muscle_weight | 0.54914575 |
| 115 | MP0000566_synostosis | 0.54429726 |
| 116 | MP0005166_decreased_susceptibility_to | 0.53593301 |
| 117 | MP0005623_abnormal_meninges_morphology | 0.52451416 |
| 118 | MP0001485_abnormal_pinna_reflex | 0.52339862 |
| 119 | MP0002234_abnormal_pharynx_morphology | 0.51912962 |
| 120 | MP0003172_abnormal_lysosome_physiology | 0.51058655 |
| 121 | MP0003861_abnormal_nervous_system | 0.49463660 |
| 122 | MP0003956_abnormal_body_size | 0.48466631 |
| 123 | MP0002876_abnormal_thyroid_physiology | 0.48091820 |
| 124 | MP0001943_abnormal_respiration | 0.47902273 |
| 125 | MP0010769_abnormal_survival | 0.46753233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 8.32951528 |
| 2 | Focal motor seizures (HP:0011153) | 8.06146906 |
| 3 | Focal seizures (HP:0007359) | 5.96701495 |
| 4 | Visual hallucinations (HP:0002367) | 5.36831034 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.65272598 |
| 6 | Atonic seizures (HP:0010819) | 4.05116539 |
| 7 | Febrile seizures (HP:0002373) | 4.03556784 |
| 8 | Absence seizures (HP:0002121) | 4.02876738 |
| 9 | Generalized tonic-clonic seizures (HP:0002069) | 3.85118550 |
| 10 | Action tremor (HP:0002345) | 3.82073148 |
| 11 | Poor eye contact (HP:0000817) | 3.80422450 |
| 12 | Dialeptic seizures (HP:0011146) | 3.74110688 |
| 13 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.73869442 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.72846452 |
| 15 | Ankle clonus (HP:0011448) | 3.66924877 |
| 16 | Broad-based gait (HP:0002136) | 3.66621967 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.64121186 |
| 18 | Depression (HP:0000716) | 3.54305657 |
| 19 | Abnormal social behavior (HP:0012433) | 3.41172302 |
| 20 | Impaired social interactions (HP:0000735) | 3.41172302 |
| 21 | Anxiety (HP:0000739) | 3.41127469 |
| 22 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.35259729 |
| 23 | Torticollis (HP:0000473) | 3.31505051 |
| 24 | Dysdiadochokinesis (HP:0002075) | 3.29436346 |
| 25 | Cerebral hypomyelination (HP:0006808) | 3.27567193 |
| 26 | Papilledema (HP:0001085) | 3.26856866 |
| 27 | Abnormality of the lower motor neuron (HP:0002366) | 3.25171818 |
| 28 | Mutism (HP:0002300) | 3.20814849 |
| 29 | Dysmetria (HP:0001310) | 3.20218751 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 3.19632549 |
| 31 | Annular pancreas (HP:0001734) | 3.16353505 |
| 32 | Postural instability (HP:0002172) | 3.11870612 |
| 33 | Hyperventilation (HP:0002883) | 3.07149968 |
| 34 | Focal dystonia (HP:0004373) | 3.06132085 |
| 35 | Amblyopia (HP:0000646) | 3.03189513 |
| 36 | Cerebral inclusion bodies (HP:0100314) | 3.02012454 |
| 37 | Urinary urgency (HP:0000012) | 2.94191166 |
| 38 | Neurofibrillary tangles (HP:0002185) | 2.93328986 |
| 39 | Abnormal eating behavior (HP:0100738) | 2.91874792 |
| 40 | Truncal ataxia (HP:0002078) | 2.89867615 |
| 41 | Stereotypic behavior (HP:0000733) | 2.88365517 |
| 42 | Craniofacial dystonia (HP:0012179) | 2.77092462 |
| 43 | Impaired smooth pursuit (HP:0007772) | 2.73226414 |
| 44 | Bradykinesia (HP:0002067) | 2.66829415 |
| 45 | Spastic gait (HP:0002064) | 2.64826768 |
| 46 | Excessive salivation (HP:0003781) | 2.63655585 |
| 47 | Drooling (HP:0002307) | 2.63655585 |
| 48 | Megalencephaly (HP:0001355) | 2.59393016 |
| 49 | Intention tremor (HP:0002080) | 2.59376555 |
| 50 | Resting tremor (HP:0002322) | 2.57829645 |
| 51 | Hemiparesis (HP:0001269) | 2.53633117 |
| 52 | Impaired vibratory sensation (HP:0002495) | 2.52788698 |
| 53 | Abnormality of binocular vision (HP:0011514) | 2.51093670 |
| 54 | Diplopia (HP:0000651) | 2.51093670 |
| 55 | Genetic anticipation (HP:0003743) | 2.50780715 |
| 56 | Scanning speech (HP:0002168) | 2.50533163 |
| 57 | Pointed chin (HP:0000307) | 2.50212652 |
| 58 | Ankyloglossia (HP:0010296) | 2.49191971 |
| 59 | Sleep apnea (HP:0010535) | 2.47898783 |
| 60 | Progressive inability to walk (HP:0002505) | 2.45103977 |
| 61 | Epileptiform EEG discharges (HP:0011182) | 2.44346328 |
| 62 | Abnormality of the labia minora (HP:0012880) | 2.38117382 |
| 63 | Akinesia (HP:0002304) | 2.37419739 |
| 64 | Dysmetric saccades (HP:0000641) | 2.35205970 |
| 65 | Ventricular fibrillation (HP:0001663) | 2.34024492 |
| 66 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.33167377 |
| 67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.32783567 |
| 68 | Lower limb amyotrophy (HP:0007210) | 2.32636309 |
| 69 | Tetraplegia (HP:0002445) | 2.27325716 |
| 70 | Termporal pattern (HP:0011008) | 2.27126710 |
| 71 | Insidious onset (HP:0003587) | 2.27126710 |
| 72 | Hepatoblastoma (HP:0002884) | 2.26686888 |
| 73 | Lower limb muscle weakness (HP:0007340) | 2.26318438 |
| 74 | Hemiplegia (HP:0002301) | 2.25670092 |
| 75 | Spastic tetraparesis (HP:0001285) | 2.25258058 |
| 76 | Status epilepticus (HP:0002133) | 2.24477616 |
| 77 | Obstructive sleep apnea (HP:0002870) | 2.22650911 |
| 78 | Hypsarrhythmia (HP:0002521) | 2.21950749 |
| 79 | Amyotrophic lateral sclerosis (HP:0007354) | 2.21491159 |
| 80 | Peripheral hypomyelination (HP:0007182) | 2.19925879 |
| 81 | Insomnia (HP:0100785) | 2.17452277 |
| 82 | Poor suck (HP:0002033) | 2.16483806 |
| 83 | Absent speech (HP:0001344) | 2.16211872 |
| 84 | Fetal akinesia sequence (HP:0001989) | 2.15365659 |
| 85 | CNS hypomyelination (HP:0003429) | 2.14927933 |
| 86 | Generalized myoclonic seizures (HP:0002123) | 2.13790916 |
| 87 | Spastic tetraplegia (HP:0002510) | 2.10790375 |
| 88 | Incomplete penetrance (HP:0003829) | 2.09955000 |
| 89 | Failure to thrive in infancy (HP:0001531) | 2.09790967 |
| 90 | Abnormality of the corticospinal tract (HP:0002492) | 2.09007888 |
| 91 | Abnormal EKG (HP:0003115) | 2.07761343 |
| 92 | Delusions (HP:0000746) | 2.07220573 |
| 93 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.06716874 |
| 94 | Clonus (HP:0002169) | 2.05006224 |
| 95 | Limb dystonia (HP:0002451) | 2.04216455 |
| 96 | Apathy (HP:0000741) | 2.03292840 |
| 97 | Inability to walk (HP:0002540) | 2.01614166 |
| 98 | Lower limb asymmetry (HP:0100559) | 2.00078720 |
| 99 | Neuronal loss in central nervous system (HP:0002529) | 1.99441502 |
| 100 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.98836044 |
| 101 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.98836044 |
| 102 | Rapidly progressive (HP:0003678) | 1.94458151 |
| 103 | Bundle branch block (HP:0011710) | 1.93838554 |
| 104 | Inappropriate behavior (HP:0000719) | 1.93648829 |
| 105 | Gait ataxia (HP:0002066) | 1.89992170 |
| 106 | Gait imbalance (HP:0002141) | 1.85316937 |
| 107 | Rigidity (HP:0002063) | 1.84496077 |
| 108 | Abnormality of oral frenula (HP:0000190) | 1.83618429 |
| 109 | Specific learning disability (HP:0001328) | 1.81678749 |
| 110 | Split foot (HP:0001839) | 1.81437441 |
| 111 | Polyphagia (HP:0002591) | 1.81139174 |
| 112 | Hand muscle atrophy (HP:0009130) | 1.79075628 |
| 113 | Hypoplasia of the corpus callosum (HP:0002079) | 1.78812204 |
| 114 | Abnormality of the periventricular white matter (HP:0002518) | 1.77778176 |
| 115 | Cortical dysplasia (HP:0002539) | 1.77771255 |
| 116 | Diminished motivation (HP:0000745) | 1.77223487 |
| 117 | Prolonged QT interval (HP:0001657) | 1.75902018 |
| 118 | Anosmia (HP:0000458) | 1.72677860 |
| 119 | Abnormality of saccadic eye movements (HP:0000570) | 1.72592450 |
| 120 | Psychosis (HP:0000709) | 1.72298138 |
| 121 | Abnormality of salivation (HP:0100755) | 1.72167988 |
| 122 | Intellectual disability, profound (HP:0002187) | 1.69025576 |
| 123 | Choreoathetosis (HP:0001266) | 1.60875032 |
| 124 | Agitation (HP:0000713) | 1.58820167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.18274235 |
| 2 | NTRK3 | 4.52981197 |
| 3 | MAP3K9 | 4.08350187 |
| 4 | MARK1 | 2.80389446 |
| 5 | DAPK2 | 2.75340363 |
| 6 | KSR2 | 2.66397242 |
| 7 | MINK1 | 2.60654993 |
| 8 | RIPK4 | 2.50077182 |
| 9 | PRKD3 | 2.46752471 |
| 10 | MAP3K4 | 2.46692489 |
| 11 | PAK6 | 2.10455813 |
| 12 | CAMKK1 | 1.97596826 |
| 13 | MAP2K7 | 1.94984623 |
| 14 | NTRK2 | 1.89414816 |
| 15 | KSR1 | 1.89252236 |
| 16 | NTRK1 | 1.82135584 |
| 17 | ARAF | 1.81203415 |
| 18 | MAP3K13 | 1.80900885 |
| 19 | DAPK1 | 1.74016620 |
| 20 | CDK5 | 1.61331570 |
| 21 | FES | 1.57010188 |
| 22 | MAP2K4 | 1.52930655 |
| 23 | DYRK2 | 1.51282289 |
| 24 | SIK2 | 1.50866605 |
| 25 | MAP3K12 | 1.45622640 |
| 26 | PRPF4B | 1.41349359 |
| 27 | TNIK | 1.40453585 |
| 28 | MAP3K2 | 1.33371347 |
| 29 | STK38 | 1.27827352 |
| 30 | TYRO3 | 1.25308946 |
| 31 | PLK2 | 1.23960944 |
| 32 | RAF1 | 1.22015342 |
| 33 | TAOK1 | 1.20192583 |
| 34 | GRK5 | 1.15327685 |
| 35 | PRKCG | 1.13589587 |
| 36 | PTK2B | 1.04701082 |
| 37 | PNCK | 1.03433447 |
| 38 | MAPK13 | 1.00551304 |
| 39 | CAMK1D | 0.99481518 |
| 40 | BMPR2 | 0.97313153 |
| 41 | CAMK1 | 0.94869322 |
| 42 | BCR | 0.93359306 |
| 43 | CAMK2A | 0.92293145 |
| 44 | CDK18 | 0.90024201 |
| 45 | CDK15 | 0.89436469 |
| 46 | CASK | 0.88140315 |
| 47 | UHMK1 | 0.87843934 |
| 48 | CDK19 | 0.87205042 |
| 49 | CDK14 | 0.85650735 |
| 50 | CAMKK2 | 0.84959733 |
| 51 | PRKCH | 0.83976973 |
| 52 | STK11 | 0.83030174 |
| 53 | CAMK2B | 0.82978132 |
| 54 | LATS2 | 0.81603786 |
| 55 | PKN1 | 0.80679163 |
| 56 | PINK1 | 0.79383500 |
| 57 | WNK3 | 0.78702941 |
| 58 | CDK11A | 0.78348010 |
| 59 | PHKG1 | 0.77249218 |
| 60 | PHKG2 | 0.77249218 |
| 61 | MARK2 | 0.75377071 |
| 62 | SGK223 | 0.73947931 |
| 63 | SGK494 | 0.73947931 |
| 64 | RET | 0.73835498 |
| 65 | ALK | 0.72933325 |
| 66 | PDK1 | 0.72209908 |
| 67 | SGK1 | 0.71512574 |
| 68 | PDPK1 | 0.69521985 |
| 69 | MAP3K1 | 0.68517986 |
| 70 | CSNK1G3 | 0.61553284 |
| 71 | DYRK1A | 0.60805944 |
| 72 | PAK3 | 0.58994409 |
| 73 | NEK1 | 0.58413349 |
| 74 | NME1 | 0.56423484 |
| 75 | SGK2 | 0.56229935 |
| 76 | PRKCZ | 0.55716631 |
| 77 | LMTK2 | 0.55486905 |
| 78 | SGK3 | 0.54925581 |
| 79 | CSNK1E | 0.54110372 |
| 80 | MAP3K7 | 0.53394353 |
| 81 | CSNK1A1L | 0.53334904 |
| 82 | FGR | 0.52492398 |
| 83 | TNK2 | 0.51749796 |
| 84 | FGFR2 | 0.49221610 |
| 85 | TRIM28 | 0.49178651 |
| 86 | RPS6KA3 | 0.48757812 |
| 87 | FYN | 0.48704086 |
| 88 | MAP2K1 | 0.47891639 |
| 89 | CSNK1G2 | 0.47395747 |
| 90 | ERBB2 | 0.47257229 |
| 91 | DMPK | 0.46388004 |
| 92 | DAPK3 | 0.46039077 |
| 93 | BRSK1 | 0.45960798 |
| 94 | NEK6 | 0.45675481 |
| 95 | MAPK10 | 0.45199151 |
| 96 | DYRK1B | 0.44770551 |
| 97 | CSNK1G1 | 0.44551905 |
| 98 | LIMK1 | 0.42678548 |
| 99 | CCNB1 | 0.40745660 |
| 100 | PLK3 | 0.40309092 |
| 101 | PRKCE | 0.39767862 |
| 102 | MAPK12 | 0.39579045 |
| 103 | CAMK4 | 0.39549721 |
| 104 | MOS | 0.39158060 |
| 105 | CAMK2D | 0.38965837 |
| 106 | BRAF | 0.38904387 |
| 107 | CSNK1D | 0.38645914 |
| 108 | PRKD2 | 0.37342621 |
| 109 | SCYL2 | 0.37260031 |
| 110 | OXSR1 | 0.36460581 |
| 111 | RIPK1 | 0.36349708 |
| 112 | MAPK8 | 0.35243629 |
| 113 | CAMK2G | 0.34440411 |
| 114 | FER | 0.34375057 |
| 115 | GSK3B | 0.32821628 |
| 116 | PRKACA | 0.32392017 |
| 117 | CSNK1A1 | 0.32239013 |
| 118 | CDC42BPA | 0.32215591 |
| 119 | MAP3K6 | 0.31923589 |
| 120 | PRKG1 | 0.31331948 |
| 121 | PRKDC | 0.31189394 |
| 122 | PRKCB | 0.30430889 |
| 123 | CAMK1G | 0.27308749 |
| 124 | MAP3K11 | 0.26974110 |
| 125 | PRKCA | 0.26307781 |
| 126 | TSSK6 | 0.23697468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.51630275 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.17408993 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.01000142 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.88575175 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.83369068 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.69491091 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.67891418 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.64844914 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.64630125 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.63106448 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.28883923 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.22469179 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.17386002 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.04799295 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.94331666 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.93604846 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.91475168 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.88526092 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.82962976 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.79928294 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.71109157 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.70750317 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.65571844 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.60089543 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.57332788 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.55865002 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.45886489 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.38860827 |
| 29 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.34229083 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33610064 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.29644892 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.28032245 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.26476463 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.22822266 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16965281 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.14106749 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13478782 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10091581 |
| 39 | Melanogenesis_Homo sapiens_hsa04916 | 1.07881806 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07718437 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.06331098 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02393136 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98460945 |
| 44 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97480960 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96988141 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95052127 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94526157 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92297112 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90606541 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.84729463 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84635204 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81148164 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81021069 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80989820 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79459885 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78933822 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77900961 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76082694 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74257710 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72174559 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.70406285 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69935033 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69041519 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68073538 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66092757 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65736474 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64761373 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62951150 |
| 69 | Alcoholism_Homo sapiens_hsa05034 | 0.62501824 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59904074 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58424669 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57743736 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57725093 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56056185 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55865061 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54481495 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52502690 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 0.50399131 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.50329715 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.48594489 |
| 81 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48430249 |
| 82 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47473894 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47311100 |
| 84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46662035 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44827409 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44372281 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42780109 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42692478 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42526052 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.39835848 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39549033 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38970808 |
| 93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38498606 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37845727 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37829244 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37759041 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.37686622 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36760052 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35782869 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35095718 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34295198 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33422719 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32961688 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32838634 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32232209 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30613972 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29786606 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29569857 |
| 109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.29536763 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.27447914 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27348792 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.25025669 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24275347 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.23857447 |
| 115 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.23499821 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22963887 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20461510 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19630605 |

